The phosphor screen scanner market has been growing rapidly over the past few years owing to its widespread applications in medical imaging. Phosphor screen scanners are x-ray detectors used for digitizing conventional radiographic films and phosphor plates in medical imaging applications such as radiography and fluoroscopy. They offer significant advantages over conventional wet films such as quick retrieval of digital images, improved image processing capabilities, and reduced chemical waste. The rising demand for digital radiography systems from hospitals and diagnostic centers is a key factor driving the adoption of phosphor screen scanners.
The Global Phosphor Screen Scanner Market Size is estimated to be valued at US$ 288 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2024 to 2030.
Factors such as the growing geriatric population, increasing prevalence of chronic diseases, and technological advancements in medical imaging systems are fueling the market growth. However, high costs associated with digital radiography systems and lack of necessary infrastructure in developing regions are some challenges hampering the widespread adoption of phosphor screen scanners.
Key players operating in the phosphor screen scanner market include Intomics, GENinCode, NanoString, Tepnel Pharma Services Limited, Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc, QIAGEN, Quest Diagnostics Incorporated, Medtronic, Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, bioMérieux SA, F. Hoffmann-La Roche Ltd, Eli Lilly & Company, GlaxoSmithKline plc, Cepheid, AstraZeneca PLC, Myriad Genetics, Inc., Bristol-Myers Squibb Company, and Foundation Medicine, Inc. Major players are focusing on new product launches, collaborations, and geographic expansion to strengthen their global presence.
The rise of telehealth and teleradiology during the pandemic has created lucrative opportunities for phosphor screen scanner manufacturers to tap the remote healthcare market. Companies are investing in cloud-based solutions and remote diagnostic capabilities to meet the growing demand.
North America dominated the global market in 2020 led by advanced healthcare infrastructure and high adoption of medical imaging technologies in the region. However, Asia Pacific is expected to witness the highest growth during the forecast period with China and India emerging as profitable markets. Key players are shifting their focus towards these developing nations through partnerships and joint ventures.
Market drivers and restrain
The key driver for the phosphor screen scanner market is the increasing demand for digital radiography systems from hospitals and diagnostic centers. Digital radiography offers numerous advantages such as quick retrieval of high-quality digital images, improved workflow efficiency, reduced radiation dose, and easy storage and sharing of reports over traditional wet films. This has accelerated the replacement of conventional analog radiography with CR and DR systems installed with phosphor screen scanners.
Another major driver is the rising geriatric population globally which is prone to chronic diseases requiring diagnostic imaging tests. According to the United Nations, the population aged 60 years and above is expected to nearly double by 2050. This will significantly burden healthcare systems and boost the demand for medical imaging modalities including X-rays using phosphor screen scanners.
On the other hand, high costs associated with digital radiography solutions are a key restraining factor hampering their widespread adoption, especially in price-sensitive developing markets. Standalone phosphor screen scanners and fully integrated DR systems incur substantial investments, which may not be feasible for certain regions with limited budgets. Furthermore, lack of necessary IT infrastructure in rural areas of developing countries poses challenges for telehealth and cloud-based services of phosphor screen scanner manufacturers. These factors could moderately impact the market growth during the forecast period.
The phosphor screen scanner market is dominating by the Hospitals sub segment. Hospitals widely use phosphor screen scanners for diagnostic applications like DNA microarray analysis, tissue microarray analysis etc. This is because hospitals perform large volume of diagnostic tests on daily basis which requires high throughput scanning devices like phosphor screen scanners.
The academic research institutes sub segment is the fastest growing segment in the phosphor screen scanner market. This is because academic research institutes are increasingly adopting phosphor screen scanners for research in fields like genomics, proteomics and pharmacogenomics studies which require analysis of DNA/RNA samples.
The North America region dominates the phosphor screen scanner market currently. This is due to presence of large pharmaceutical and biotechnology companies conducting extensive R&D in drug discovery and development using high throughput screening platforms like phosphor screen scanners in the region. The high adoption of precision medicine approach and companion diagnostics development is also driving the demand for phosphor screen scanners in North America.
The Asia Pacific region is poised to be the fastest growing region in the phosphor screen scanner market during the forecast period. This is attributed to rising R&D investments by pharmaceutical and biotechnology players for core research as well as clinical trials in countries like China, India and South Korea. The growing initiatives by governments to promote local manufacturing is also pushing the adoption of diagnostic devices like phosphor screen scanners in Asia Pacific region.
Get More Insights on This Topic: https://www.ukwebwire.com/phosphor-screen-scanner-market-trends-growth-and-regional-outlook-2024-2030/